Progression-free survival assessment to second line hormone therapy by pretherapeutic [18F]-FDG and [18F]-FES PET-CT in positive estrogen receptors metastatic breast cancer patients: preliminary results.

被引：0
|
作者：
Maucherat, Bruno [1 ]
Campion, Loic [2 ]
Le Duc-Pennec, Alexandra [3 ]
Girault, Sylvie [4 ]
Alberini, Jean-Louis [5 ]
Ferrer, Ludovic [6 ,7 ]
Allam, Nadia [8 ]
Bodere, Francoise [9 ,10 ]
Bouvet, Yann
Rousseau, Caroline [2 ]
机构：
[1] ICO Canc Ctr Rene Gauducheau, St Herblain, France
[2] Inst Cancerol IOuest, Ctr Rene Gauducheau, Angers, France
[3] Univ Hosp, Brest, France
[4] ICO Canc Ctr Paul Papin, Angers, France
[5] Georges Francois Leclerc Res Canc Ctr, Dijon, France
[6] ICO Rene Gauducheau, Dept Med Phys, St Herblain, France
[7] CRCINA, UMR 1232, INSERM, Nantes, France
[8] Inst Cancerol Louest, Angers, France
[9] Univ Hosp, Nantes, France
[10] Zionexa, Aubiere, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P337
引用
收藏
页数：3
相关论文
共 50 条
  • [31] New approach to production and quality control of 16α-[18F] fluoroestradiol ([18F] FES: The effective functional molecular imaging probe for positive estrogen receptors breast cancer
    Dadashov, Z.
    Shukurov, R.
    Valiyev, M.
    Eryilmaz, K.
    Balashov, M.
    Novruzov, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S743 - S743
  • [32] Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
    Schweighofer-Zwink, Gregor
    Manafi-Farid, Reyhaneh
    Kolblinger, Peter
    Hehenwarter, Lukas
    Harsini, Sara
    Pirich, Christian
    Beheshti, Mohsen
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 146
  • [33] 18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
    Xu, Xiaojun
    Sun, Xun
    Ma, Ling
    Zhang, Huangqi
    Ji, Wenbin
    Xia, Xiaotian
    Lan, Xiaoli
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [34] 18F FDG PET/CT Evaluation of Neoadjuvant Chemotherapy Response Course in Patients with Breast Cancer: Preliminary Data
    Nanni, C.
    Castellucci, P.
    Franchi, R.
    Farsad, M.
    Sperandi, F.
    Zamagni, C.
    Martoni, A.
    Pontone, G.
    Pandolfi, S.
    Magagnoli, G.
    Sansovini, M.
    Santagata, F.
    Zanarini, R.
    Malfatti, V.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S158 - S158
  • [35] The heterogeneity of estrogen receptor (ER) expression in metastatic breast cancer is measured by [18F]-fluoroestradiol (FES) PET.
    Mankoff, DA
    Tewson, TJ
    Peterson, LM
    Stekhova, S
    Gralow, JR
    Livingston, RB
    Moe, RE
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 28P - 28P
  • [36] Comparison of FLT-(18F) and FDG-(18F) to visualize cancer spread while staging locally advanced breast cancer with PET/CT: preliminary data
    Grahek, D
    Gligorov, J
    Beerblock, K
    Selle, F
    Segura, C
    Chopier, J
    Salem, C
    Antoine, M
    Barranger, E
    Montravers, F
    Gutman, F
    Kerrou, K
    De Beco, V
    Marsault, C
    Lotz, JP
    Uzan, S
    Talbot, JN
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S88 - S88
  • [37] Potentials of [18F]FDG PET/CT for the Assessment of Pathological Response to Neoadjuvant Therapy in Breast Cancer: A Prospective Study
    Gelardi, F.
    De Sanctis, R.
    Tiberio, P.
    Zanca, R.
    Fernandes, B.
    Rodari, M.
    Chiti, A.
    Sollini, M.
    Antunovic, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S151 - S151
  • [38] Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer
    Pedersen, Mette A.
    Munk, Ole L.
    Dias, Andre H.
    Steffensen, Johanne H.
    Moller, Anders L.
    Johnsson, Anna Lyhne
    Hansen, Kim Vang
    Bender, Dirk
    Jakobsen, Steen
    Busk, Morten
    Gormsen, Lars C.
    Tramm, Trine
    Borgquist, Signe
    Vendelbo, Mikkel H.
    EJNMMI RESEARCH, 2024, 14 (01)
  • [39] Analyzing the Estrogen Receptor Status of Liver Metastases with [18F]-FES-PET in Patients with Breast Cancer
    Boers, Jorianne
    Loudini, Naila
    de Haas, Robbert J.
    Willemsen, Antoon T. M.
    van der Vegt, Bert
    de Vries, Elisabeth G. E.
    Hospers, Geke A. P.
    Schroder, Carolina P.
    Glaudemans, Andor W. J. M.
    de Vries, Erik F. J.
    DIAGNOSTICS, 2021, 11 (11)
  • [40] Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer
    Mette A. Pedersen
    Ole L. Munk
    André H. Dias
    Johanne H. Steffensen
    Anders L. Møller
    Anna Lyhne Johnsson
    Kim Vang Hansen
    Dirk Bender
    Steen Jakobsen
    Morten Busk
    Lars C. Gormsen
    Trine Tramm
    Signe Borgquist
    Mikkel H. Vendelbo
    EJNMMI Research, 14
12345